The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
But there's there are biochemical arguments to be made that estrone and in particular one of the metabolites of estrone and I think it's four hydroxyestone is the the is the is the estrogen that is driving breast cancer. So in an estrogen sensitive breast cancer, given that you have so many estrogens, is it more likely that one is responsible than another?
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.